It turns out, they like us, or so they say. Biomedical researchers should take note that for the second year in a row, U.S. Senate appropriators have declared funding the National Institutes of Health a...
June 22, 2011
Dr. Keith Flaherty from Massachusetts General Hospital presents to the Congressional Biomedical Research Caucus on New Therapies for Melanoma. Dr Flaherty discusses cutting edge research for the treatment of advanced melanoma, including immunotherapies, antibodies, and chemotherapeutic combinations. Dr. Flaherty is internationally known for his expertise in clinical and translational research directed on finding molecularly targeted therapies aimed at treating the underlying cause of melanoma.